Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 37

Publication Record

Connections

Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses.
Hu JR, Duncan MS, Morgans AK, Brown JD, Meijers WC, Freiberg MS, Salem JE, Beckman JA, Moslehi JJ
(2020) Arterioscler Thromb Vasc Biol 40: e55-e64
MeSH Terms: Androgen Antagonists, Antineoplastic Agents, Hormonal, Cardiotoxicity, Cardiovascular Diseases, Cardiovascular System, Humans, Male, Prostatic Neoplasms, Risk Assessment, Risk Factors, Treatment Outcome
Added May 29, 2020
0 Communities
2 Members
0 Resources
11 MeSH Terms
Heart failure and atrial tachyarrhythmia on abiraterone: A pharmacovigilance study.
Bretagne M, Lebrun-Vignes B, Pariente A, Shaffer CM, Malouf GG, Dureau P, Potey C, Funck-Brentano C, Roden DM, Moslehi JJ, Salem JE
(2020) Arch Cardiovasc Dis 113: 9-21
MeSH Terms: Adverse Drug Reaction Reporting Systems, Aged, Aged, 80 and over, Androgen Antagonists, Androstenes, Antineoplastic Agents, Hormonal, Cardiotoxicity, Databases, Factual, Heart Failure, Humans, Male, Middle Aged, Pharmacovigilance, Phenylthiohydantoin, Prostatic Neoplasms, Retrospective Studies, Risk Assessment, Risk Factors, Tachycardia, Supraventricular, Time Factors
Added November 12, 2019
0 Communities
2 Members
0 Resources
20 MeSH Terms
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer.
Formisano L, Lu Y, Servetto A, Hanker AB, Jansen VM, Bauer JA, Sudhan DR, Guerrero-Zotano AL, Croessmann S, Guo Y, Ericsson PG, Lee KM, Nixon MJ, Schwarz LJ, Sanders ME, Dugger TC, Cruz MR, Behdad A, Cristofanilli M, Bardia A, O'Shaughnessy J, Nagy RJ, Lanman RB, Solovieff N, He W, Miller M, Su F, Shyr Y, Mayer IA, Balko JM, Arteaga CL
(2019) Nat Commun 10: 1373
MeSH Terms: Aminopyridines, Animals, Antineoplastic Agents, Hormonal, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Circulating Tumor DNA, Cyclin D1, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Drug Resistance, Neoplasm, Female, Fulvestrant, High-Throughput Nucleotide Sequencing, Humans, MCF-7 Cells, Mice, Mutation, Naphthalenes, Piperazines, Progression-Free Survival, Proportional Hazards Models, Protein Kinase Inhibitors, Purines, Pyrazoles, Pyridines, Quinolines, Quinoxalines, Receptor, Fibroblast Growth Factor, Type 1, Receptor, Fibroblast Growth Factor, Type 2, Receptors, Estrogen, Signal Transduction, Xenograft Model Antitumor Assays
Added April 2, 2019
0 Communities
1 Members
0 Resources
32 MeSH Terms
Cardiology Patient Page. ABCDE Steps for Heart and Vascular Wellness Following a Prostate Cancer Diagnosis.
Guan J, Khambhati J, Jones LW, Morgans A, Allaf M, Penson DF, Moslehi J
(2015) Circulation 132: e218-20
MeSH Terms: Adenocarcinoma, Androgen Antagonists, Androgens, Antineoplastic Agents, Hormonal, Cardiovascular Diseases, Comorbidity, Diabetes Mellitus, Diet, Disease Susceptibility, Exercise, Health Promotion, Humans, Hypercholesterolemia, Hypertension, Life Style, Male, Neoplasms, Hormone-Dependent, Prostatic Neoplasms, Risk Factors, Smoking Cessation, Survivors
Added February 4, 2016
0 Communities
2 Members
0 Resources
21 MeSH Terms
Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.
Goetz MP, Sun JX, Suman VJ, Silva GO, Perou CM, Nakamura Y, Cox NJ, Stephens PJ, Miller VA, Ross JS, Chen D, Safgren SL, Kuffel MJ, Ames MM, Kalari KR, Gomez HL, Gonzalez-Angulo AM, Burgues O, Brauch HB, Ingle JN, Ratain MJ, Yelensky R
(2014) J Natl Cancer Inst 107:
MeSH Terms: Adult, Aged, Antineoplastic Agents, Hormonal, Biomarkers, Tumor, Breast Neoplasms, Cytochrome P-450 CYP2D6, DNA, Neoplasm, Disease-Free Survival, Female, Formaldehyde, Genotype, Humans, Loss of Heterozygosity, Middle Aged, Mouth Mucosa, Paraffin Embedding, Receptor, ErbB-2, Receptors, Estrogen, Survival Analysis, Tamoxifen, Tissue Fixation
Added February 22, 2016
0 Communities
1 Members
0 Resources
21 MeSH Terms
Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer.
Ziehr DR, Chen MH, Zhang D, Braccioforte MH, Moran BJ, Mahal BA, Hyatt AS, Basaria SS, Beard CJ, Beckman JA, Choueiri TK, D'Amico AV, Hoffman KE, Hu JC, Martin NE, Sweeney CJ, Trinh QD, Nguyen PL
(2015) BJU Int 116: 358-65
MeSH Terms: Aged, Aged, 80 and over, Androgen Antagonists, Antineoplastic Agents, Hormonal, Coronary Disease, Goserelin, Humans, Leuprolide, Male, Middle Aged, Prostatic Neoplasms, Retrospective Studies, Risk Factors
Added January 15, 2016
0 Communities
1 Members
0 Resources
13 MeSH Terms
ErbB3 downregulation enhances luminal breast tumor response to antiestrogens.
Morrison MM, Hutchinson K, Williams MM, Stanford JC, Balko JM, Young C, Kuba MG, Sánchez V, Williams AJ, Hicks DJ, Arteaga CL, Prat A, Perou CM, Earp HS, Massarweh S, Cook RS
(2013) J Clin Invest 123: 4329-43
MeSH Terms: Animals, Antibodies, Monoclonal, Antineoplastic Agents, Hormonal, Breast Neoplasms, Cell Proliferation, Cell Survival, Down-Regulation, Drug Resistance, Neoplasm, Drug Synergism, ErbB Receptors, Estradiol, Estrogen Receptor Modulators, Female, Fulvestrant, Gene Dosage, Gene Expression, Gene Expression Regulation, Neoplastic, Humans, MCF-7 Cells, Mice, Mice, Inbred BALB C, Mice, Nude, Oligonucleotide Array Sequence Analysis, Receptor, ErbB-2, Receptor, ErbB-3, Signal Transduction, Survival Analysis, Transcriptome, Xenograft Model Antitumor Assays
Added March 7, 2014
1 Communities
3 Members
0 Resources
29 MeSH Terms
Castration-resistant prostate cancer: AUA Guideline.
Cookson MS, Roth BJ, Dahm P, Engstrom C, Freedland SJ, Hussain M, Lin DW, Lowrance WT, Murad MH, Oh WK, Penson DF, Kibel AS
(2013) J Urol 190: 429-38
MeSH Terms: Androgen Antagonists, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Antineoplastic Combined Chemotherapy Protocols, Drug Administration Schedule, Drug Resistance, Neoplasm, Glucocorticoids, Humans, Immunotherapy, Male, Prostatic Neoplasms
Added March 7, 2014
0 Communities
1 Members
0 Resources
11 MeSH Terms
Role of mTOR inhibition in preventing resistance and restoring sensitivity to hormone-targeted and HER2-targeted therapies in breast cancer.
Mayer I
(2013) Clin Adv Hematol Oncol 11: 217-24
MeSH Terms: Antineoplastic Agents, Hormonal, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Clinical Trials as Topic, Drug Resistance, Neoplasm, Female, Humans, Phosphatidylinositol 3-Kinases, Protein Kinase Inhibitors, Proto-Oncogene Proteins c-akt, Receptor, ErbB-2, Signal Transduction, TOR Serine-Threonine Kinases
Added March 7, 2014
0 Communities
1 Members
0 Resources
13 MeSH Terms
ADAR1 is essential for intestinal homeostasis and stem cell maintenance.
Qiu W, Wang X, Buchanan M, He K, Sharma R, Zhang L, Wang Q, Yu J
(2013) Cell Death Dis 4: e599
MeSH Terms: Adenosine Deaminase, Animals, Antineoplastic Agents, Hormonal, Apoptosis, Cell Differentiation, Cells, Cultured, Endoplasmic Reticulum Stress, Inflammation, Interferons, Intestinal Mucosa, Intestines, Mice, Mice, Knockout, RNA-Binding Proteins, Receptors, G-Protein-Coupled, Signal Transduction, Stem Cells, Tamoxifen, Wnt Proteins
Added July 28, 2015
0 Communities
1 Members
0 Resources
19 MeSH Terms